Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor

por Waaler, Jo, Leenders, Ruben G. G., Sowa, Sven T., Alam Brinch, Shoshy, Lycke, Max, Nieczypor, Piotr, Aertssen, Sjoerd, Murthy, Sudarshan, Galera-Prat, Albert, Damen, Eddy, Wegert, Anita, Nazaré, Marc, Lehtiö, Lari, Krauss, Stefan
Publicado 2020

Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II

por Leenders, Ruben G. G., Brinch, Shoshy Alam, Sowa, Sven T., Amundsen-Isaksen, Enya, Galera-Prat, Albert, Murthy, Sudarshan, Aertssen, Sjoerd, Smits, Johannes N., Nieczypor, Piotr, Damen, Eddy, Wegert, Anita, Nazaré, Marc, Lehtiö, Lari, Waaler, Jo, Krauss, Stefan
Publicado 2021

The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models

por Brinch, Shoshy A., Amundsen-Isaksen, Enya, Espada, Sandra, Hammarström, Clara, Aizenshtadt, Aleksandra, Olsen, Petter A., Holmen, Lone, Høyem, Merete, Scholz, Hanne, Grødeland, Gunnveig, Sowa, Sven T., Galera-Prat, Albert, Lehtiö, Lari, Meerts, Ilonka A.T.M., Leenders, Ruben G.G., Wegert, Anita, Krauss, Stefan, Waaler, Jo
Publicado 2022